The Research, Scholarship, and Artistic Achievement Awards nomination deadline has been extended to May 31, 2024. Click here for more information.

CRISPR-Based Methods and Novel compositions for Treating Vascular Disorders


Tulane University is actively seeking commercial entities to further develop and commercialize CRISPR-based compositions and methods of use to impair or promote angiogenesis.


Controlling angiogenesis in patients has implication in many disease states including tumor growth, age-related macular degeneration, and cancer metastasis.

Current Work

These compositions have been explored with in vitro assays including EC-fibroblast co-culture.


Bo Yu, PhD

Available For

Exclusive License in a Field
Non-exclusive License
Scientific Collaboration

For more information, please contact: